Related references
Note: Only part of the references are listed.Targeting Huntingtin Expression in Patients with Huntington's Disease
Sarah J. Tabrizi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Molecular Pathogenesis in Huntington's Disease
S. N. Illarioshkin et al.
BIOCHEMISTRY-MOSCOW (2018)
Edaravone: a new hope for deadly amyotrophic lateral sclerosis
R. Bhandari et al.
DRUGS OF TODAY (2018)
Thiol-based antioxidants elicit mitochondrial oxidation via respiratory complex III
Vladimir L. Kolossov et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
Cdk5-mediated mitochondrial fission: A key player in dopaminergic toxicity in Huntington's disease
Marta Cherubini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington's disease
Maria Manczak et al.
HUMAN MOLECULAR GENETICS (2015)
VGF and striatal cell damage in in vitro and in vivo models of Huntington's disease
Yasuhiro Noda et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Geldanamycin attenuates 3-nitropropionic acid-induced apoptosis and JNK activation through the expression of HSP 70 in striatal cells
Yong-Joon Choi et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
CDK5-dependent inhibitory phosphorylation of Drp1 during neuronal maturation
Bongki Cho et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2014)
Recent advances into the understanding of mitochondrial fission
Kirstin Elgass et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration
Xing Guo et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux
Huikyong Lee et al.
HUMAN MOLECULAR GENETICS (2012)
Proteomic Analysis of Wild-type and Mutant Huntingtin-associated Proteins in Mouse Brains Identifies Unique Interactions and Involvement in Protein Synthesis
Brady P. Culver et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Metabolic State Determines Sensitivity to Cellular Stress in Huntington Disease: Normalization by Activation of PPARγ
Youngnam N. Jin et al.
PLOS ONE (2012)
Converging Pathways in the Occurrence of Endoplasmic Reticulum (ER) Stress in Huntington's Disease
R. Vidal et al.
CURRENT MOLECULAR MEDICINE (2011)
Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity
Wenjun Song et al.
NATURE MEDICINE (2011)
Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease
Jinho Kim et al.
HUMAN MOLECULAR GENETICS (2010)
Huntington's disease: the case for genetic modifiers
James F. Gusella et al.
GENOME MEDICINE (2009)
Aggregation of Expanded Huntingtin in the Brains of Patients With Huntington Disease
Guylaine Hoffner et al.
PRION (2007)
Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington's disease knock-in striatal cells
ZK Mao et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease
E Brouillet et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway
QM Ruan et al.
HUMAN MOLECULAR GENETICS (2004)
Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells
F Trettel et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
